OPSALIN: A phase II placebo-controlled randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with carboplatin (Cb) and paclitaxel (P). Background: Cvac ...
Breast cancer is the most common cancer among women worldwide, and >1 million women are diagnosed with breast cancer every year. Although breast cancer is one of leading causes of cancer deaths in the ...
Aspirin use and mortality in women with stage I-III breast cancer: A population-based study. Impact of expression levels of mRNA HER2 and ESR1 on the pathologic complete remission (pCR) rate after ...